{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:25:11Z","timestamp":1762104311821,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008809","name":"University of Hail","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012964","name":"Minist\u00e8re de l\u2019Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bulcan.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T15:47:30Z","timestamp":1622044050000},"page":"718-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An overview of genetic predisposition to familial hematological malignancies"],"prefix":"10.1016","volume":"108","author":[{"given":"Walid Sabri","family":"Hamadou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouha","family":"Bouali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsen","family":"Besbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Bardakci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif Jamal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riadh","family":"Badraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagay","family":"Sobol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra","family":"Soua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2021.03.013_bib0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10689-016-9909-1","article-title":"Introduction to special issue of Familial Cancer","volume":"15","author":"Lynch","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bulcan.2021.03.013_bib0165","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2018-06-858597","article-title":"Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms","volume":"132","author":"Sud","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0170","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.2019001362","article-title":"Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk","volume":"134","author":"Sud","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0175","doi-asserted-by":"crossref","first-page":"118979","DOI":"10.1016\/j.lfs.2020.118979","article-title":"Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma","volume":"268","author":"Gamboa-Cede\u00f1o","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bulcan.2021.03.013_bib0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.13295","article-title":"Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing","volume":"170","author":"Ristolainen","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0185","first-page":"8","article-title":"Identification of familial hodgkin lymphoma predisposing genes using whole genome sequencing","author":"Srivastava","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/leu.2015.272","article-title":"Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries","volume":"30","author":"Fallah","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12094-015-1379-7","article-title":"Familial hematological malignancies: ASXL1 gene investigation","volume":"18","author":"Hamadou","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jamaoncol.2019.2203","article-title":"Association of germline BRCA 2 mutations with the risk of pediatric or adolescent non\u2013hodgkin lymphoma","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2021.03.013_bib0205","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1080\/10428194.2020.1737690","article-title":"Additional B-cell malignancies in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL)","volume":"61","author":"Meacham","year":"2020","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.bulcan.2021.03.013_bib0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bulcan.2016.10.016","article-title":"ARLTS1, potential candidate gene in familial aggregation of hematological malignancies","volume":"104","author":"Hamadou","year":"2017","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0215","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1038\/s41467-019-11582-2","article-title":"Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics","volume":"10","author":"Speedy","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0220","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2016-01-695692","article-title":"Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia","volume":"128","author":"Speedy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/or.2014.3568","article-title":"A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study","volume":"33","author":"Blackburn","year":"2015","journal-title":"Oncol Rep"},{"issue":"9","key":"10.1016\/j.bulcan.2021.03.013_bib0230","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41375-019-0446-4","article-title":"Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia","volume":"33","author":"Jebaraj","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11864-014-0323-3","article-title":"Familial Leukemias","volume":"16","author":"Wiernik","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0245","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/leu.2016.124","article-title":"Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia","volume":"30","author":"Cardoso","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0250","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"S\u00e9bert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0255","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0260","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/10428194.2017.1359742","article-title":"ETV6 and NOTCH1 germline variants in adult acute leukemia","volume":"59","author":"Dirse","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0265","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0270","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood.2019004292","article-title":"Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia","volume":"136","author":"Matsumura","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0275","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41375-019-0675-6","article-title":"Familial myeloid malignancies with germline TET2 mutation","volume":"34","author":"Duployez","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0280","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia","volume":"33","author":"Churchman","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0285","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12885-015-1549-6","article-title":"Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes","volume":"15","author":"Spinella","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0290","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/bloodadvances.2018030635","article-title":"Germline deletion of ETV6 in familial acute lymphoblastic leukemia","volume":"3","author":"Rampersaud","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0295","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2021.03.013_bib0300","doi-asserted-by":"crossref","first-page":"106008","DOI":"10.1016\/j.intimp.2019.106008","article-title":"Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1\/VLA-4","volume":"80","author":"Yu","year":"2020","journal-title":"Int Immunopharmacol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:20:24Z","timestamp":1762104024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0007455121001788"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.03.013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of genetic predisposition to familial hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}